药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dioxaphetyl butyrate
Dimercaprol
Ertugliflozin may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Ammonium chloride
Ertugliflozin may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Aceclofenac
Ertugliflozin may increase the excretion rate of Aceclofenac which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Gadofosveset trisodium
Ertugliflozin may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Desvenlafaxine
Ertugliflozin may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Flupirtine
Ertugliflozin may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Telavancin
Ertugliflozin may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Nalmefene
Ertugliflozin may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Prasugrel
Ertugliflozin may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Icatibant
Ertugliflozin may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Ipilimumab
Ertugliflozin may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Pentaerythritol tetranitrate
Ertugliflozin may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Brivaracetam
Ertugliflozin may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Clevidipine
Ertugliflozin may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Milnacipran
Ertugliflozin may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Pegaptanib
Ertugliflozin may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Lorcaserin
Ertugliflozin may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Roflumilast
Ertugliflozin may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Chloral hydrate
Ertugliflozin may increase the excretion rate of Chloral hydrate which could result in a lower serum level and potentially a reduction in efficacy.
Dioxaphetyl butyrate
Bromazepam
Ertugliflozin may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.